Table 2.
Baseline characteristics of participants in primary trial and qualitative study. Values are numbers (percentages) unless stated otherwise
| Characteristics | Primary trial (n=855) | Qualitative study (n=29) |
|---|---|---|
| Women | 534 (62.4) | 18 (65) |
| Mean (SD) age (years) | 85.5 (4.0) | 83.3 (3.1) |
| Living alone | 531 (61.1) | 21 (65.5) |
| Mean (SD) abbreviated mental test | 8.9 (1.5) | 9.2 (0.7) |
| Mean (SD) total No of drugs | 6.3 (2.6) | 6.7 (2.6) |
| Monitored dose system | 152* (18.6) | 9 (31) |
| Social class† | 333‡ (42) | 11 (37.9) |
| Baseline diagnosis: | ||
| Cardiovascular | 278 (32.5) | 10 (34.5) |
| Musculoskeletal | 126 (14.7) | 8 (27.6) |
| Gastrointestinal | 101 (11.8) | 0 (0.00) |
| Respiratory | 97 (11.3) | 4 (13.7) |
| Neurological | 65 (7.6) | 2 (6.8) |
| Other | 188 (22.0) | 5 (17.4) |
*Data on 817 patients.
†I, II, or IIInm.
‡Employment details available for 793 patients.